CoChat

Role of Indoxyl Sulfate in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Experimental and Clinical Effects of Oral Sorbent AST‐120

Open access
Niwa, Toshimitsu · 2011 · Therapeutic Apheresis and Dialysis
Cited by 112

The DOI matches its Crossref record.

Abstract

Indoxyl sulfate, a nephrovascular uremic toxin, is markedly accumulated in the serum of chronic kidney disease (CKD) patients. Because of its protein binding ability, its removal by hemodialysis is not as efficient as that of non‐protein bound uremic toxins. AST‐120 delays the progression of CKD by adsorbing indole, a precursor of indoxyl sulfate, in the intestines, and consequently reduces the serum levels of indoxyl sulfate. Indoxyl sulfate exhibits cellular toxicity in renal tubular cells, glomerular mesangial cells, vascular smooth muscle cells, vascular endothelial cells, cardiac myocytes, and osteoblasts by inducing oxidative stress. Indoxyl sulfate stimulates the progression of CKD by increasing the expression of fibrogenic genes such as transforming growth factor‐β1 in CKD rats. Indoxyl sulfate stimulates aortic calcification in hypertensive rats; thus, indoxyl sulfate is involved in the progression of CKD and cardiovascular disease. Experimental and clinical data demonstrate that AST‐120 delays the progression not only of chronic kidney disease, but also of cardiovascular disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1744-9987.2010.00882.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 112

Metadata

Authors
Niwa, T.
Venue
Therapeutic Apheresis and Dialysis
Publisher
Wiley
Published
2011-01-25
Volume
15
Issue
2
Pages
120-124
ISSN
  • 1091-6660 (ISSN-L)
  • 1744-9979
  • 1744-9987
OpenAlex
W1651661950
Cited by
112
References
0
FWCI
5.26
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Role of Indoxyl Sulfate in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Experimental and Clinical Effects of Oral Sorbent AST‐120. https://app.cochat.ai/papers/10.1111/j.1744-9987.2010.00882.x
The paper
Niwa, T. (2011). Role of Indoxyl Sulfate in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Experimental and Clinical Effects of Oral Sorbent AST‐120. Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/j.1744-9987.2010.00882.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.